共 50 条
- [21] Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III studyMEDICINE, 2023, 102 (47) : E36122Lee, Seung-AhHong, Soon JunSung, Jung-HoonKim, Kyung-SooKim, Seong HwanCho, Jin ManChun, Sung WanLee, Sang RokKim, Chul SikKim, Tae NyunKim, Dae HyeokPark, Hwan-CheolKim, Byung JinKim, Hyun-SookChoi, Ji-YongHong, Young JoonChung, Joong WhaYoon, Seong BoLee, Sang-HakLee, Cheol Whan
- [22] A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive DisorderJOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (05) : 575 - 582Jacobsen, Paula L.Mahableshwarkar, Atul R.Serenko, MichaelChan, SerenaTrivedi, Madhukar H.
- [23] A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitisJOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2004, 14 (01) : 56 - 63Hampel, FHowland, WVan Bavel, JRatner, P
- [24] Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitorsUsual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory studyJournal of Gastroenterology, 2019, 54 : 972 - 983Toshihisa TakeuchiHitoshi HongoTsuguhiro KimuraYuichi KojimaSatoshi HaradaKazuhiro OtaNozomi TakeuchiTakao NoguchiTakuya InoueMitsuyuki MuranoKazuhide Higuchi
- [25] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VONOPRAZAN (20 MG ONCE DAILY) COMPARED TO LANSOPRAZOLE (30 MG ONCE-DAILY) IN PATIENTS WITH EROSIVE ESOPHAGITIS (EE)GASTROENTEROLOGY, 2018, 154 (06) : S237 - S237Chen, MinhuChun, Hoon JaiSheu, Bor-ShyangChong, Chui FungFunao, NobuoZhou, WenGoh, Khean Lee
- [27] Randomized clinical trial: A double-blind, proof-of-concept, phase 2 study evaluating the efficacy and safety of vonoprazan 20 or 40 mg versus esomeprazole 40 mg in patients with symptomatic gastro-esophageal reflux disease and partial response to a healing dose of a proton-pump inhibitorNEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (01):Tack, JanVladimirov, BorislavHorny, IvoChong, Chui FungEisner, JessicaCzerniak, RichardTakanami, Yohei
- [28] Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of LifeMEDICAL SCIENCE MONITOR, 2015, 21 : 4111 - 4121Takeshima, FuminaoHashiguchi, KeiichiOnitsuka, YasunoriTanigawa, KenMinami, HitomiMatsushima, KayokoAkazawa, YukoShiozawa, KenYamaguchi, NaoyukiTaura, NaotaOhnita, KenIchikawa, TatsukiIsomoto, HajimeNakao, Kazuhiko
- [30] A Randomized, Double-blinded, Placebo- controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot StudyJOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (02) : 265 - 275Lee, Ju YupKim, NayoungYoon, HyukShin, Cheol MinPark, Young SooLee, Dong Ho